Let's catch up on some of the new facilities announced in the Pharma industry the past couple weeks.
Fierce Biotech reports that Eisai will build a new R&D center in India. It will be their first R&D building outside of Japan. The facility is budgeted at $50 M and will employ 100 focused on formulation development.
in-Pharma Technologist.com reports that Tanabe Reesearch Labs will open a new facility in San Diego. The site will focus on mAbs and other biologicals aimed at autoimmune diseases - diabetes & RA. The new site is part of the parent's, Mitsubishi Tanabe Pharma, global R&D expansion plan which calls for aggressive in- and out-licensing in US and Europe.
That gives us stories in India and the US, now another from Europe. Again, in-Pharma Technologist.com reports that Baxter will expand its European R&D operations into Belgium. Located in Alliance Park Braine l'Alleud, Belgium, the new facility will house scientists working onnew projects from "conception to registration". These will be plasma based therapeutics, vaccines and packaging and delivery systems.
Posted by Bruce Lehr June 28th 2010.